Connect with us

International

T2 Biosystems (NASDAQ: TTOO) Breaks Ground: FDA Clearance, Market Trends, and Healthcare Impact

Shares of T2 Biosystems (NASDAQ:TTOO) are soaring up over 20% today on the heels of receiving a 510(k) clearance for its T2Biothreat from the FDA. This…

Published

on

Shares of T2 Biosystems (NASDAQ:TTOO) are soaring up over 20% today on the heels of receiving a 510(k) clearance for its T2Biothreat from the FDA. This unique test directly detects six biothreat pathogens from a blood sample.

Spotting Biothreats Faster:

T2Biothreat Panel is a game-changer, being the first and only FDA-approved product that can spot these critical biothreat pathogens simultaneously. T2 Biosystems proudly stands as the first U.S. company to achieve this milestone, reshaping the field of biothreat detection.

Big Investor Sells:

Interestingly while celebrating this achievement, a significant investor, CR Group (CRG), decided to sell off a substantial chunk of shares. This sell-off, totaling 24.81 million shares, took place between Sept. 20 and Sept. 26. The timing of this sell-off alongside the FDA clearance raises some eyebrows.

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

New CDC Guidelines:

Regardless of CR Group selling, there still appears to be a massive opportunity according to many retail investors. Following new CDC guidelines, the U.S. government now mandates that all hospitals in the country must adopt rapid testing protocols to combat the sepsis pandemic by 2026, or risk losing Medicare funding.

Buying opportunity of the year!!! Update
byu/den1183 inTTOOstock

T2 Biosystems stands as the exclusive FDA-cleared product capable of achieving 100% accurate sepsis detection within 3 to 5 hours. Anticipating widespread adoption of T2 instruments in hospitals, the CEO foresees significant revenue generation, potentially reaching $1.3 billion annually, given the mandate.

This development drastically alters the landscape, potentially influencing the stock’s trajectory positively. With the ongoing surge in manufacturing hires and likely acceleration in orders, coupled with potential government contracts or international sales, many beleive T2 Biosystems presents an undervalued opportunity for investors.

What Borrowing Costs Tell Us:

Another interesting indicator to look at is the cost to borrow (CTB) fee. In terms of TTOO’s case, the stock has seen a massive surge in CTB fees, indicating a high demand from short sellers. When compared to the average CTB fee for other stocks, it’s pretty drastic. While this is typically not a very positive sign, retail investors seem to be buzzing with interest, given there also could be a potential short squeeze if enough buying comes in to trap the shorts.

Better News for Patients:

But let’s not forget the real impact and that’s what TTOO can do for patients. @ChengKeki a user from Twitter also shared an article about Butler Memorial Hospital and their approach to Sepsis. The hospital came up with a 2 step approach to expedite patient care.  They’re utilizing the Beckman Coulter automation line to identify changes in a person’s blood cells that might indicate the development of sepsis. Which apparently has only been used in Europe and they’re the first in the US with the technology. Then shortly after, they use T2 Biosystems panels that as you know, quicken the process from 36 hours, to just 3-5 hours.

Catching sepsis quickly is crucial because it’s a life-threatening condition that rapidly progresses throughout your body and can lead to death if not promptly diagnosed and treated. Sepsis occurs when the body responds improperly to an infection, causing widespread inflammation and potentially damages multiple organ systems. Early detection allows for immediate medical intervention.

Conclusion:

T2 Biosystems is hitting major milestones, not only in the market but in improving critical healthcare processes. The company is also a major hit with retail investors and continues to trade an astronomical amount of shares daily, the current average is ~115M shares. The FDA approval and its implications, along with the positive shift in sepsis diagnosis, showcase T2 Biosystems’ growing role in healthcare. Keep an eye on how this progresses—it’s exciting for both investors and patients alike.

We will update you on TTOO when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Picture by jarmoluk from Pixabay

 

The post T2 Biosystems (NASDAQ: TTOO) Breaks Ground: FDA Clearance, Market Trends, and Healthcare Impact first appeared on Micro Cap Daily.

The post T2 Biosystems (NASDAQ: TTOO) Breaks Ground: FDA Clearance, Market Trends, and Healthcare Impact appeared first on Micro Cap Daily.

Read More

Continue Reading

International

This new McDonald’s China menu item is a meat lover’s dream

The fast-food giant has delivered a new sandwich, and you might want to ask your doctor about it before you eat it.

Published

on

While the Big Mac has the word "big" in it, McDonald's hasn't really staked a major claim as the fast-food chain for people looking for the meatiest sandwiches.

Arguably, at least in the U.S., Burger King and Wendy's (WEN) - Get Free Report have stronger claims to that dubious title. 

Wendy's, for example, has the Dave's Triple and the Big Bacon Classic Triple on its menu while it also lets customers order a burger with a total of four hamburger patties if they so choose.

The menu at Restaurant Brands International's  (QSR) - Get Free Report Burger King features a Triple Whopper, which actually contains fewer calories (1,170) than the two-patty Bacon King. Burger King will also sell you a four-patty burger, but you have to make that order in person, not through the chain's app or website.

Wendy's does not appear to limit how many patties you can add to your sandwich, at least when you order through Uber Eats. In theory, if you want 25, or maybe 50, burger patties on your Baconator, the chain will allow it — although at some point wrapping the burger will become a problem.

For its part, McDonald's features a triple cheeseburger on its regular menu, but that's made from three regular-size (1.6-ounce or 45-gram) patties. The biggest item by meat weight is the Double Quarter Pounder, which offers a full half-pound of beef. 

Like its rivals, MCD (probably) will sell you more burger patties if you ask at its counter. It allows extra patty sales through its app on some sandwiches, but not others. The chain also maxes out at three patties (although customers could likely order more in-person as there does not appear to be a policy preventing that). 

All these burgers, however, pale in comparison to a massive sandwich the chain has been selling in China.

A regular Big Mac seems modest compared to some hamburgers.

Image source: Cate Gillon/Getty Images

McDonald's builds a bigger Mac

McDonald's locations around the world — especially in Japan and China — seem to equate the American brand with massive burgers. A new burger from the chain's locations in China sets a new standard when it comes to massive sandwiches, although the burger patties do get some help/

"McDonald's China's Bu Su Zhi Ba Double Layer Beef Burger is a mouthful of meat that puts U.S. patties to shame. True to its name, which translates to German Sausage Double Beef Burger, this item packs two burger patties and two sausages between its buns. This gives customers a protein-heavy dish, with little more than a layer of mustard to round it out — it doesn't contain any of the more traditional McDonald's toppings like lettuce, tomato, or pickles," Mashed shared.

The fast-food giant has never offered sausages in its U.S. restaurants and it has only sold hot dogs on a very limited basis in the U.S. McDonald's founder was famously against the chain selling hot dogs because people would not know what was inside them.

China shows McDonald's the way

McDonald's CEO Chris Kempczinski actually visited some of his chain's locations in China this year. He talked about what he learned during the company's second-quarter earnings call.

"Visiting China truly brought to life the power of a highly digitized economy and our potential for global growth moving forward. With about 90% of our business currently coming through digital channels in that market, it was remarkable to see how the market has forged digital relationships with customers," he said.

Kempczinski was also impressed with other aspects of the company's operations in China.

"China is also making tremendous progress in running the restaurants more efficiently, all with the use of data and technology. This will provide great learnings for the rest of our system," he added.

The chain is also innovating in the delivery space in the market.

"Another recent example of innovation I was able to see firsthand during my visit to China is the use of food lockers at busy locations with high in-store traffic. Upon arrival, delivery couriers can quickly unlock the designated locker and grab the customer's order without even entering the restaurant, removing friction for both the kitchen and the courier," Kempczinski said.

Read More

Continue Reading

International

Coca-Cola surprisingly ending most sales of Aha sparkling water

The beverage giant has decided to mostly walk away from one of its biggest bets in recent years.

Published

on

Coca-Cola sells some of the most popular beverages in the world and it generally has the muscle to make any new products it sells successful. 

Of course, there have been some pretty big Coca-Cola (KO) - Get Free Report failures in recent years where the company has tried to capitalize on a trend. Few people remember Vault, an effort to compete with rival PepsiCo's (PEP) - Get Free Report Mountain Dew. And 2009's Green Tea Coke never got enough attention to be remembered or forgotten.

Related: Coca-Cola adds new Coke and Sprite flavors that could be big hits

The company's biggest recent failure, however, might be Coca-Cola Energy, an attempt to take on Monster and Red Bull. That drink lasted less than a year before the company pulled the plug.

It was a surprising move because the idea of Coca-Cola Energy made sense. It was an attempt by the No. 1 beverage company to leverage its namesake brand to get into the exploding energy-drink market.

Consumers, however, were never that interested. They may have sampled it, but the product was never popular enough to win enough market share for Coke to commit to the product long term.

That same script has repeated in another explosively growing market. Coca-Cola launched its Aha sparkling-water brand to compete with market leaders LaCroix and Pepsi's Bubly. It was a massive launch — Coca-Cola's first brand debut since 2006 — that simply never captured the public's attention.

Coca-Cola has had some high-profile failures.

Image source: Shutterstock

Coca-Cola is largely winding down Aha        

Sparkling water has been a growing category led by the massive success of LaCroix. It makes sense that Coca-Cola wanted to get in on the trend, but Aha has not made a significant market impact. The company thus has decided to wind down, but not fully eliminate, the brand. 

"In 2024, the beverages will only be available in 'focused channels' and in Coca-Cola Freestyle machines, and will continue to be sold in Canada," the beverage giant told Food Dive.

Coca-Cola isn't giving up on sparkling water. The company intends to focus its attention on growing its premium Topo Chico brand in the same space. 

Sales have fallen for Aha, which replaced Coca-Cola's previous effort in the sparkling-water space, Dasani Sparkling. The brand has less than a 2% share of the total market.

Coca-Cola executives have said that they believe Topo Chico can become the company's next billion-dollar brand. The company recently launched a hard-seltzer, an alcoholic version of the popular brand. 

Coca-Cola sees some headwinds

Coca-Cola sales were flat by volume in the second quarter. Chief Executive James Quincey explained why in the company's Q2-earnings call.

"We have seen some willingness to switch to private-label brands in certain categories," he said. "Across the sector, consumers are increasingly cost-conscious. They're looking for value and stocking up on items on sale." 

Quincey believes that Coca-Cola is well-positioned to handle the current market.

"Our pricing is largely in place and is expected to moderate as we cycle pricing initiatives from the prior year. It's more important than ever to be consumer-centric and to partner with customers to provide affordable and premium propositions, which deliver value through basket and incidence growth," he added.

And, while the company has been focused on growing sales outside soda, its namesake beverage continues to be a major driver.

"During the quarter, we gained volume and value share by linking Coca-Cola to consumption occasions and engaging consumers through local experiences. A great example is our Recipe for Magic, which was activated in more than 50 markets and celebrates consuming Coca-Cola with meals," he said.

Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.

Read More

Continue Reading

International

Volkswagen EV Sales In China Surge 90%, Despite Overall Sales Slumping

Volkswagen EV Sales In China Surge 90%, Despite Overall Sales Slumping

In the third quarter, Volkswagen AG saw a robust increase in sales…

Published

on

Volkswagen EV Sales In China Surge 90%, Despite Overall Sales Slumping

In the third quarter, Volkswagen AG saw a robust increase in sales in Europe and North America, which helped counterbalance a decline in the Chinese market.

The automaker saw its Chinese deliveries fall 5.8% during Q3, according to a Friday morning wrap-up by Bloomberg. But global deliveries rose by 7.4%, amounting to 2.34 million vehicles delivered for Volkswagen. Specifically, sales surged 9.9% worldwide in the month of September alone.

In China, the company faced a slump as third-quarter deliveries dipped to 837,200, and September sales experienced a slight decline of 0.9%.

Despite the decline in China, EV sales continue to be robust in the country. The delivery of all-electric vehicles in China surged by an impressive 90% to 21,662 vehicles in September, largely propelled by ID.3 sales, which outstripped overall market gains of 12%.

Meanwhile, Western Europe witnessed a significant 21% uptick in sales to 799,300 during the third quarter, and North American sales climbed 12% to 257,400.

We noted in late September that competition was so robust in China, some automakers like Mitsubishi were pulling out of the geography. Back in early summer, Volkswagen had slowed its production of EVs due to weakening sales. 

"We are experiencing strong customer reluctance in the electric vehicle sector," Manfred Wulff, head of the works council for Volkswagen's Emden plant said in June. That appears to no longer be the case - at least in China. 

We noted last week that the EV market in China is growing so quickly and prices are plunging at such a rapid rate, that the EU is investigating, claiming that emerging data indicates a probable surge in government-backed, low-cost imports, putting an already fragile EU sector at immediate risk.

The EU has launched an inquiry focused specifically on newly produced electric vehicles intended for carrying nine or fewer passengers; motorcycles, however, are not part of the current probe and the investigation is expected to wrap up within a year.

China's Ministry of Commerce objected to the investigation, claiming it "is solely based on assumption and lacks sufficient evidence," Bloomberg reported last week.

We noted weeks ago that Tesla's EVs would be included in the investigation. EU executive vice-president Valdis Dombrovskis said in late September that there was “sufficient prima facie evidence” to support the probe. We had previously written about the EU's investigation and Beijing's response via The Global Times. 

As we noted last month, China responded to the investigation via The Global Times, claiming that the EU's probe would likely "backfire" and that the EU's economy would suffer as a result. The publication said that "...as the EU wields trade protectionist measures to suppress China's EV industry, the European economy may suffer."

The article claimed that the EU isn't bothered by the subsidies, but rather "the rapidly growing market influence of Chinese EV companies" and "the concern that homegrown European enterprises may be unable to compete."

"Clearly, Europe is afraid," The Global Times wrote. "They are afraid of competition from China, so they want to seek trade protectionism as a protective umbrella for European auto makers who are slowly transitioning toward electrification." China added that the EU should "have enough courage to face competition from their Chinese counterparts directly."

Tyler Durden Sat, 10/14/2023 - 07:35

Read More

Continue Reading

Trending